共 389 条
[1]
Viswanathan S(2019)Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT(R)) Mesenchymal Stromal Cell committee position statement on nomenclature Cytotherapy. 21 1019-1024
[2]
Shi Y(2009)Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks Bone Marrow Transplant. 43 821-828
[3]
Galipeau J(2010)Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications Stem Cell Res Ther. 1 2-614
[4]
Krampera M(2010)Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders Stem Cells Dev. 19 607-2100
[5]
Leblanc K(2015)Mesenchymal stem cell therapy for autoimmune disease: risks and rewards Stem Cells Dev. 24 2091-687
[6]
Martin I(2006)Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells Cell Biol Int. 30 681-1691
[7]
Nolta J(2014)Tryptophan concentration is the main mediator of the capacity of adipose mesenchymal stromal cells to inhibit T-lymphocyte proliferation in vitro Cytotherapy. 16 1679-1570
[8]
Phinney DG(2015)What makes umbilical cord tissue-derived mesenchymal stromal cells superior immunomodulators when compared to bone marrow derived mesenchymal stromal cells? Stem Cells Int. 2015 583984-153
[9]
Sensebe L(2015)Human bone marrow-derived mesenchymal stromal cells differentially inhibit cytokine production by peripheral blood monocytes subpopulations and myeloid dendritic cells Stem Cells Int. 2015 819084-317
[10]
Tyndall A(2015)Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells Stem Cell Res Ther. 6 3-525